Longboard Pharmaceuticals, Inc. Proceeds from Stock Options Exercised
Longboard Pharmaceuticals, Inc. reported Proceeds from Stock Options Exercised of $664.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-11-07
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2024-09-30 was $591.00K, a 239.66% increase year-over-year.
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2024-06-30 was $25.00K, a 47.92% decline year-over-year.
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2024-03-31 was $48.00K.
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was $268.00K.
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2023 was $490.00K.
- Longboard Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2022 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-09-30 | $591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $616.00K derived: sum of 2 quarters · filed 2024-11-07 | $664.00K 10-Q · filed 2024-11-07 | $932.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $73.00K 10-Q · filed 2024-08-01 | $341.00K derived: sum of 3 quarters · filed 2024-08-01 | $515.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $48.00K 10-Q · filed 2024-05-02 | $316.00K derived: sum of 2 quarters · filed 2024-05-02 | $490.00K derived: sum of 3 quarters · filed 2024-11-07 | $538.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $442.00K derived: sum of 2 quarters · filed 2024-11-07 | $490.00K derived: sum of 3 quarters · filed 2024-11-07 | $490.00K 10-K · filed 2024-03-12 |
| 2023-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $222.00K derived: sum of 2 quarters · filed 2024-11-07 | $222.00K 10-Q · filed 2024-11-07 | $222.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $48.00K 10-Q · filed 2024-08-01 | $48.00K derived: sum of 3 quarters · filed 2024-08-01 | $48.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2024-05-02 | $0.00 derived: sum of 3 quarters · filed 2024-05-02 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | $0.00 10-K · filed 2024-03-12 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 |